• 2438 Citations
  • 22 h-Index
1984 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giancarlo Bisagni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
letrozole Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Epirubicin Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 2438 Citations
  • 22 h-Index
  • 99 Article
  • 2 Review article
1 Citation (Scopus)

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Confidence Intervals
Proportional Hazards Models
5 Citations (Scopus)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p., mdz055.

Research output: Contribution to journalArticle

Open Access
letrozole
Hormones
Breast Neoplasms
Therapeutics
Drug Therapy

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Therapeutics
Aromatase Inhibitors
Datasets
11 Citations (Scopus)
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms